ALNY - ALNYLAM PHARMACEUTICALS, INC.

QQQ $ 480.15 $ -1.01 (-0.21 %)

DIA $ 408.54 $ -0.55 (-0.13 %)

SPY $ 559.70 $ -0.23 (-0.04 %)

TLT $ 98.68 $ 0.78 (0.8 %)

GLD $ 232.46 $ 0.85 (0.37 %)

Previous Close

$ 280.76

Open

Bid

$ 280.53 x 200

Ask

-- x --

Day's Range

-- - --

52 Week Range

$ 141.98 - $ 282.68

Volume

1,052,628

Average Volume

Market Cap

35.58B

Beta (5Y Monthly)

$ 0.71

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-01-2024	06-30-2024	10-Q
2	05-02-2024	03-31-2024	10-Q
3	02-15-2024	12-31-2023	10-K
4	11-02-2023	09-30-2023	10-Q
5	08-03-2023	06-30-2023	10-Q
6	05-04-2023	03-31-2023	10-Q
7	02-23-2023	12-31-2022	10-K
8	10-27-2022	09-30-2022	10-Q
9	07-28-2022	06-30-2022	10-Q
10	04-28-2022	03-31-2022	10-Q
11	02-10-2022	12-31-2021	10-K
12	10-28-2021	09-30-2021	10-Q
13	08-03-2021	06-30-2021	10-Q
14	04-29-2021	03-31-2021	10-Q
15	02-11-2021	12-31-2020	10-K
16	11-05-2020	09-30-2020	10-Q
17	08-06-2020	06-30-2020	10-Q
18	05-06-2020	03-31-2020	10-Q
19	02-13-2020	12-31-2019	10-K
20	10-31-2019	09-30-2019	10-Q
21	08-06-2019	06-30-2019	10-Q
22	05-02-2019	03-31-2019	10-Q
23	02-14-2019	12-31-2018	10-K
24	11-07-2018	09-30-2018	10-Q
25	08-02-2018	06-30-2018	10-Q
26	05-04-2018	03-31-2018	10-Q
27	02-15-2018	12-31-2017	10-K
28	11-07-2017	09-30-2017	10-Q
29	08-09-2017	06-30-2017	10-Q
30	05-05-2017	03-31-2017	10-Q
31	02-15-2017	12-31-2016	10-K
32	11-03-2016	09-30-2016	10-Q
33	08-04-2016	06-30-2016	10-Q
34	05-04-2016	03-31-2016	10-Q
35	02-12-2016	12-31-2015	10-K
36	11-09-2015	09-30-2015	10-Q
37	08-07-2015	06-30-2015	10-Q
38	05-08-2015	03-31-2015	10-Q
39	02-13-2015	12-31-2014	10-K
40	11-06-2014	09-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Reiterates Buy on Alny...
08/20/2024 11:22:33

HC Wainwright & Co. analyst Patrick Trucchio reiterates Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Buy and maintains $...

Goldman Sachs Upgrades Alnylam Pharmaceuti...
08/16/2024 14:31:03

Goldman Sachs analyst Salveen Richter upgrades Alnylam Pharmaceuticals (NASDAQ:ALNY) from Neutral to Buy and raises the pric...

10-health-care-stocks-with-whale-alerts-in-todays-session

10 Health Care Stocks With Whale Alerts In...
08/12/2024 17:35:22

heres-how-much-you-would-have-made-owning-alnylam-pharmaceuticals-stock-in-the-last-10-years

Here's How Much You Would Have Made Owning...
08/07/2024 21:30:18

Alnylam Pharmaceuticals To Present HELIOS-...
08/07/2024 12:14:30

Company To Host Conference Call And Investor Webcast On August 30, 2024

how-is-the-market-feeling-about-alnylam-pharmaceuticals

How Is The Market Feeling About Alnylam Ph...
08/06/2024 17:00:14

doordash-and-exact-sciences-are-among-top-10-large-cap-gainers-last-week-july-28-aug-3-are-the-others-in-your-portfolio

DoorDash And Exact Sciences Are Among Top ...
08/04/2024 14:32:50

Top 10 stocks with highest gains last week, including Exact Sciences, Alnylam Pharmaceuticals, Resmed, Coca-Cola Consolidated, ...

RBC Capital Maintains Outperform on Alnyla...
08/02/2024 19:44:39

RBC Capital analyst Luca Issi maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Outperform and raises the price target ...

Wells Fargo Maintains Equal-Weight on Alny...
08/02/2024 18:34:07

Wells Fargo analyst Tiago Fauth maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Equal-Weight and raises the price tar...

Raymond James Maintains Outperform on Alny...
08/02/2024 17:46:02

Raymond James analyst Gary Nachman maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Outperform and raises the price ta...

Goldman Sachs Maintains Neutral on Alnylam...
08/02/2024 16:23:14

Goldman Sachs analyst Salveen Richter maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Neutral and raises the price ta...

Citigroup Maintains Buy on Alnylam Pharmac...
08/02/2024 16:16:32

Citigroup analyst David Lebovitz maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Buy and raises the price target from...

Barclays Maintains Overweight on Alnylam P...
08/02/2024 14:24:14

Barclays analyst Gena Wang maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Overweight and raises the price target fro...

Canaccord Genuity Maintains Buy on Alnylam...
08/02/2024 11:44:19

Canaccord Genuity analyst Whitney Ijem maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Buy and raises the price targe...

Needham Maintains Buy on Alnylam Pharmaceu...
08/02/2024 11:06:11

Needham analyst Joseph Stringer maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Buy and raises the price target from ...

Air Products Posts Upbeat Earnings, Joins ...
08/01/2024 15:42:35

Alnylam Pharmaceuticals Updated 2024 Finan...
08/01/2024 12:10:57

Alnylam Pharmaceuticals Q2 2024 Adj. EPS $...
08/01/2024 12:09:51

ionis-rare-development-disorder-drug-candidate-could-be-differentiated-from-peer-ultragenyx-analyst

Ionis' Rare Development Disorder Drug Cand...
07/22/2024 17:04:26

Ionis Pharmaceuticals releases positive results from Phase 1/2 study of ION582 for Angelman syndrome, showing consistent clinic...

Cantor Fitzgerald Maintains Neutral on Aln...
07/22/2024 15:19:55

Cantor Fitzgerald analyst Olivia Brayer maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Neutral and raises the price ...